about
Delivery arrangements for health systems in low-income countries: an overview of systematic reviewsQuantitative evaluation of essential medicines lists: the South African case study.Exploring knowledge, attitudes, and barriers toward the use of evidence-based practice amongst academic health care practitioners in their teaching in a South African university: a pilot study.Clinical risk factors for in-hospital mortality in older adults with HIV infection: findings from a South African hospital administrative dataset.Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.The relevance of systematic reviews on pharmaceutical policy to low- and middle-income countries.Price, availability and affordability of medicines.Evaluating the effect of a proposed logistics fee cap on pharmaceuticals in South Africa--a pre and post analysisSelection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.Medicines availability at a Swaziland hospital and impact on patientsA systems approach to implementation of eLearning in medical education: five MEPI schools' journeys.Delivery arrangements for health systems in low-income countries: an overview of systematic reviews.A situational analysis of current antimicrobial governance, regulation and utilisation in South Africa.Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries.Adherence to hypertension treatment guidelines in state facilities in KwaZulu-Natal, South Africa.Evaluating adverse drug reactions among HAART patients in a resource-constrained province of South Africa.Measurement of Vaginal Microbicide Adherence Using Visual Inspection as Compared to Ultra Violet Light Assessment of Returned Empty Gel Applicators.Patients' perceptions of a rural decentralised anti-retroviral therapy management and its impact on direct out-of-pocket spending.A Comparative Cost Analysis of Antibiotic Treatment for Community Acquired Pneumonia (CAP) in Adult Inpatients at Piggs Peak Government Hospital in SwazilandDifferences in attitudes towards medication between population groups in the Durban Metropolitan Area of South AfricaCost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi ArabiaPharmaceutical policies: effects of educational or regulatory policies targeting prescribersPseudo-Generics in South Africa: A Price ComparisonThe impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014Introducing health technology assessment in TanzaniaStrategies to achieve fairer prices for generic and biosimilar medicinesNew business models for research and development with affordability requirements are needed to achieve fair pricing of medicinesComparison of patient satisfaction with pharmaceutical services of postal pharmacy and community pharmacyEvaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysisMale partner influence on family planning and contraceptive use: perspectives from community members and healthcare providers in KwaZulu-Natal, South AfricaThe impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa
P50
Q24194923-7F1D8998-2AC5-4CB0-A44E-6C1914C8B091Q30379852-6B23C89A-B300-4F2F-9644-532858FD55AFQ33523612-C7F524D6-8AE7-40AB-A2E9-D650264B5A88Q33676756-48DA5583-8E7F-4126-8A7E-4800F7752E3FQ33814840-8FB39CB5-6464-40F3-906F-F00CAE00232FQ35692830-DA924E8C-5CCB-4D65-B24C-FFFD80033C72Q35853285-DF350804-4A04-4FA6-8033-A5F35840C1B1Q35854089-8AEEC356-CFEF-46BE-8D8E-4958F7ADC048Q36243403-3D54005C-8EB0-49CF-B1F1-65D8CDC94C30Q36309833-6CC28FFD-ACF6-4E32-AF6F-809EEFC82545Q38396071-DFABDC54-E8C3-4967-BD97-505B9027D6FCQ40049818-5FA80AD3-05B2-4F13-BDF7-E0CDEEB95826Q40052811-E8DB4500-30F6-4B27-BD45-B52880A782A7Q42200395-8A50DB5F-4837-4578-BE52-10B3F6690D8FQ44389289-C5570FF6-D6A5-46A4-9A57-B68DD97C4692Q46438809-1A3C4902-A006-4D5D-982C-8216E13C09F7Q46661298-1408789F-14A2-4B9D-BED7-3C3B80E1D3C3Q47147768-ECB5B153-5682-4E12-8788-1D80E9426632Q59792421-C98179C2-79BE-40B0-A59E-FD73B2413F38Q83166753-D1A195C5-6C0D-4D39-A6E5-811086956BD8Q90995062-59C62C9E-DB35-4634-ABBE-E4D5B5004941Q91265548-C9EADE42-B7EA-4817-88AD-AD49C7E9D8E2Q92254997-357E26A1-8E24-4D1D-AB38-10AAFE49C59FQ92311710-25DD4EC1-6593-4752-9205-E58FD7FA2EF7Q92556098-A0DD3C40-DADD-45F8-BF10-1121CA094FBEQ92607898-31C8739D-CA20-4361-820A-D41BD67BEA56Q92607903-33B08F90-B975-4869-BB91-984EC404C5A5Q92620597-AE6893A0-4326-4CC0-B6A1-00840E71A262Q92665263-972ECCD7-D7F7-4BA3-B380-F6003EA0DBF2Q93020497-537CBC99-E229-4280-825D-5ACAE0D60345Q93382365-390C3A61-F2CA-470A-9473-7A21B931AEF9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fatima Suleman
@ast
Fatima Suleman
@en
Fatima Suleman
@es
Fatima Suleman
@nl
type
label
Fatima Suleman
@ast
Fatima Suleman
@en
Fatima Suleman
@es
Fatima Suleman
@nl
prefLabel
Fatima Suleman
@ast
Fatima Suleman
@en
Fatima Suleman
@es
Fatima Suleman
@nl
P106
P1153
56986030500
P31
P496
0000-0002-8559-9168